Global Preclinical Contract Research Organization (CRO) 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI06242997

Publication Date:

June 29, 2024

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Preclinical Contract Research Organization (CRO) market size was valued at US$ 14200 million in 2023. With growing demand in downstream market, the Preclinical Contract Research Organization (CRO) is forecast to a readjusted size of US$ 25960 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Preclinical Contract Research Organization (CRO) market. Preclinical Contract Research Organization (CRO) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Preclinical Contract Research Organization (CRO). 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Preclinical Contract Research Organization (CRO) market.
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Increased R&D budget for drug development is leading to rising demand for preclinical Contract Research Organization (CRO) services, and increasing early research activities in drug discovery process coupled with rising outsourcing for preclinical CRO services, thus boosting the market growth during the forecast period.
Key Features:
The report on Preclinical Contract Research Organization (CRO) market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Preclinical Contract Research Organization (CRO) market. It may include historical data, market segmentation by Type (e.g., Bioanalysis and DMPK Studies, Toxicology Testing), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Preclinical Contract Research Organization (CRO) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Preclinical Contract Research Organization (CRO) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Preclinical Contract Research Organization (CRO) industry. This include advancements in Preclinical Contract Research Organization (CRO) technology, Preclinical Contract Research Organization (CRO) new entrants, Preclinical Contract Research Organization (CRO) new investment, and other innovations that are shaping the future of Preclinical Contract Research Organization (CRO).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Preclinical Contract Research Organization (CRO) market. It includes factors influencing customer ' purchasing decisions, preferences for Preclinical Contract Research Organization (CRO) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Preclinical Contract Research Organization (CRO) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Preclinical Contract Research Organization (CRO) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Preclinical Contract Research Organization (CRO) market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Preclinical Contract Research Organization (CRO) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Preclinical Contract Research Organization (CRO) market.
麻豆原创 Segmentation:
Preclinical Contract Research Organization (CRO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others
Segmentation by application
Pharmaceutical Companies
Medical Device Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Preclinical Contract Research Organization (CRO) 麻豆原创 Size 2019-2030
2.1.2 Preclinical Contract Research Organization (CRO) 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Preclinical Contract Research Organization (CRO) Segment by Type
2.2.1 Bioanalysis and DMPK Studies
2.2.2 Toxicology Testing
2.2.3 Safety Pharmacology
2.2.4 Others
2.3 Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Type
2.3.1 Preclinical Contract Research Organization (CRO) 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Preclinical Contract Research Organization (CRO) 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Preclinical Contract Research Organization (CRO) Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Medical Device Companies
2.4.3 Others
2.5 Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Application
2.5.1 Preclinical Contract Research Organization (CRO) 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Preclinical Contract Research Organization (CRO) 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Player
3.1 Preclinical Contract Research Organization (CRO) 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Preclinical Contract Research Organization (CRO) Revenue by Players (2019-2024)
3.1.2 Global Preclinical Contract Research Organization (CRO) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Preclinical Contract Research Organization (CRO) Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preclinical Contract Research Organization (CRO) by Regions
4.1 Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Preclinical Contract Research Organization (CRO) 麻豆原创 Size Growth (2019-2024)
4.3 APAC Preclinical Contract Research Organization (CRO) 麻豆原创 Size Growth (2019-2024)
4.4 Europe Preclinical Contract Research Organization (CRO) 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Preclinical Contract Research Organization (CRO) 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Country (2019-2024)
5.2 Americas Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Type (2019-2024)
5.3 Americas Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Region (2019-2024)
6.2 APAC Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Type (2019-2024)
6.3 APAC Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Preclinical Contract Research Organization (CRO) by Country (2019-2024)
7.2 Europe Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Type (2019-2024)
7.3 Europe Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preclinical Contract Research Organization (CRO) by Region (2019-2024)
8.2 Middle East & Africa Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Preclinical Contract Research Organization (CRO) 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.1 Global Preclinical Contract Research Organization (CRO) Forecast by Regions (2025-2030)
10.1.1 Global Preclinical Contract Research Organization (CRO) Forecast by Regions (2025-2030)
10.1.2 Americas Preclinical Contract Research Organization (CRO) Forecast
10.1.3 APAC Preclinical Contract Research Organization (CRO) Forecast
10.1.4 Europe Preclinical Contract Research Organization (CRO) Forecast
10.1.5 Middle East & Africa Preclinical Contract Research Organization (CRO) Forecast
10.2 Americas Preclinical Contract Research Organization (CRO) Forecast by Country (2025-2030)
10.2.1 United States Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.2.2 Canada Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.2.3 Mexico Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.2.4 Brazil Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.3 APAC Preclinical Contract Research Organization (CRO) Forecast by Region (2025-2030)
10.3.1 China Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.3.2 Japan Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.3.3 Korea Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.3.4 Southeast Asia Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.3.5 India Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.3.6 Australia Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.4 Europe Preclinical Contract Research Organization (CRO) Forecast by Country (2025-2030)
10.4.1 Germany Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.4.2 France Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.4.3 UK Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.4.4 Italy Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.4.5 Russia Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.5 Middle East & Africa Preclinical Contract Research Organization (CRO) Forecast by Region (2025-2030)
10.5.1 Egypt Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.5.2 South Africa Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.5.3 Israel Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.5.4 Turkey Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.5.5 GCC Countries Preclinical Contract Research Organization (CRO) 麻豆原创 Forecast
10.6 Global Preclinical Contract Research Organization (CRO) Forecast by Type (2025-2030)
10.7 Global Preclinical Contract Research Organization (CRO) Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Charles River
11.1.1 Charles River Company Information
11.1.2 Charles River Preclinical Contract Research Organization (CRO) Product Offered
11.1.3 Charles River Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Charles River Main Business Overview
11.1.5 Charles River Latest Developments
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Information
11.2.2 Wuxi AppTec Preclinical Contract Research Organization (CRO) Product Offered
11.2.3 Wuxi AppTec Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Wuxi AppTec Main Business Overview
11.2.5 Wuxi AppTec Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Preclinical Contract Research Organization (CRO) Product Offered
11.3.3 Labcorp Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Preclinical Contract Research Organization (CRO) Product Offered
11.4.3 Eurofins Scientific Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 PPD, Inc.
11.5.1 PPD, Inc. Company Information
11.5.2 PPD, Inc. Preclinical Contract Research Organization (CRO) Product Offered
11.5.3 PPD, Inc. Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 PPD, Inc. Main Business Overview
11.5.5 PPD, Inc. Latest Developments
11.6 ICON Plc.
11.6.1 ICON Plc. Company Information
11.6.2 ICON Plc. Preclinical Contract Research Organization (CRO) Product Offered
11.6.3 ICON Plc. Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 ICON Plc. Main Business Overview
11.6.5 ICON Plc. Latest Developments
11.7 Pharmaron
11.7.1 Pharmaron Company Information
11.7.2 Pharmaron Preclinical Contract Research Organization (CRO) Product Offered
11.7.3 Pharmaron Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Pharmaron Main Business Overview
11.7.5 Pharmaron Latest Developments
11.8 Inotiv
11.8.1 Inotiv Company Information
11.8.2 Inotiv Preclinical Contract Research Organization (CRO) Product Offered
11.8.3 Inotiv Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Inotiv Main Business Overview
11.8.5 Inotiv Latest Developments
11.9 ChemPartner
11.9.1 ChemPartner Company Information
11.9.2 ChemPartner Preclinical Contract Research Organization (CRO) Product Offered
11.9.3 ChemPartner Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 ChemPartner Main Business Overview
11.9.5 ChemPartner Latest Developments
11.10 JOINN Lab
11.10.1 JOINN Lab Company Information
11.10.2 JOINN Lab Preclinical Contract Research Organization (CRO) Product Offered
11.10.3 JOINN Lab Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 JOINN Lab Main Business Overview
11.10.5 JOINN Lab Latest Developments
11.11 EVOTEC
11.11.1 EVOTEC Company Information
11.11.2 EVOTEC Preclinical Contract Research Organization (CRO) Product Offered
11.11.3 EVOTEC Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 EVOTEC Main Business Overview
11.11.5 EVOTEC Latest Developments
11.12 Medicilon
11.12.1 Medicilon Company Information
11.12.2 Medicilon Preclinical Contract Research Organization (CRO) Product Offered
11.12.3 Medicilon Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Medicilon Main Business Overview
11.12.5 Medicilon Latest Developments
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Information
11.13.2 Crown Bioscience Preclinical Contract Research Organization (CRO) Product Offered
11.13.3 Crown Bioscience Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Crown Bioscience Main Business Overview
11.13.5 Crown Bioscience Latest Developments
11.14 Champion Oncology
11.14.1 Champion Oncology Company Information
11.14.2 Champion Oncology Preclinical Contract Research Organization (CRO) Product Offered
11.14.3 Champion Oncology Preclinical Contract Research Organization (CRO) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Champion Oncology Main Business Overview
11.14.5 Champion Oncology Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.